Active Ingredient History
Ebselen, is a synthetic organoselenium drug molecule with anti-inflammatory, anti-oxidant and cytoprotective activity. It acts as a mimic of glutathione peroxidase and can also react with peroxynitrite. It is being investigated as a possible treatment for reperfusion injury and stroke, Ménière's disease, hearing loss and tinnitus, and bipolar disorder. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Antioxidants ()
Auditory Perception (Phase 2)
Bipolar Disorder (Phase 2)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Depressive Disorder, Treatment-Resistant (Phase 1)
Diabetes Mellitus, Type 1 (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 2/Phase 3)
Head and Neck Neoplasms (Phase 2)
Hearing Loss (Phase 2)
Hearing Loss, Noise-Induced (Phase 2)
Lung Neoplasms (Phase 2)
Meniere Disease (Phase 3)
Neoplasms (Phase 1)
Ototoxicity (Phase 2)
Peripheral Nerve Injuries (Phase 2)
Tinnitus (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue